DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR IONSYS

« Back to Dashboard

Clinical Trials for IONSYS

Trial ID	Title	Status	Sponsor	Phase	Summary
NCT00665522	A Prospective Safety Surveillance Study of Fentanyl Iontophoretic Transdermal System (40 Mcg)	Terminated	Alza Corporation, DE, USA	Phase 4	The purpose of the study is to document the use of fentanyl HCl 40 mcg system under routine conditions and obtain a more comprehensive understanding of the safety of the system and complications that may not be spontaneously reported.
NCT00666393	An Evaluation of Safety of the Fentanyl Transdermal System for Management of Acute Post-Operative Pain in Pediatric Patients	Withdrawn	Alza Corporation, DE, USA	Phase 3	The purpose of this study is to evaluate the safety and clinical utility of fentanyl HCl 40 mcg system for the management of postoperative pain in pediatric inpatients.
NCT00708318	Study Evaluating Inhaled AeroLEF (Liposome-Encapsulated Fentanyl)in Normal Healthy Subjects	Completed	YM BioSciences	Phase 1	This was a pilot, phase I, two-period, fasting, bioavailability, safety,and pharmacokinetic study evaluating single dose of i.v. fentanyl (200 µg) and single doses of 2 mL or 3 mL inhaled AeroLEF (500 µg/mL) delivered by nebulization with the AeroEclipse BAN device administered in normal healthy non-smoking subjects.
NCT00779038	Safety and Efficacy Study of Fentanyl Iontophoretic Transdermal System (ITS) for Management of Moderate to Severe Acute Pain in Participants Who Have Undergone Elective Spine or Orthopedic Surgery	Terminated	Janssen Cilag N.V./S.A.	Phase 4	The purpose of this study is to evaluate in daily clinical practice the safety and efficacy of fentanyl Iontophoretic Transdermal (through the skin) System (ITS) for management of moderate (medium level of seriousness) to severe (very serious) acute (a quick and severe) pain in participants who have undergone elective spine or orthopedic (related to bones) surgery.
NCT01804673	A Study to Evaluate the Safety and Tolerability of Fentanyl Iontophoretic Transdermal System (Fentanyl-ITS) in the Management of Post-Surgery Pain	Terminated	Janssen-Cilag G.m.b.H	Phase 4	The purpose of this study is to evaluate the safety and tolerability of the fentanyl iontophoretic transdermal (through the skin) system (fentanyl-ITS) in daily clinical practice for management of acute (a quick and severe form of illness in its early stage) moderate to severe post-operative pain (pain after surgery) including the comprehensibility and usefulness of the accompanying information material.

Clinical Trial Conditions for IONSYS

Condition Name

Condition Name for IONSYS
Intervention	Trials
Pain, Postoperative	2
Pediatrics	1
Pain	1
Healthy	1

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for IONSYS
Intervention	Trials
Pain, Postoperative	3
Spinal Injuries	1

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for IONSYS

Trials by Country

Trials by Country for IONSYS
Location	Trials
Germany	2
Netherlands	1
Belgium	1
Finland	1
Canada	1

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for IONSYS

Clinical Trial Phase

Clinical Trial Phase for IONSYS
Clinical Trial Phase	Trials
Phase 4	4
Phase 3	1
Phase 1	1

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for IONSYS
Clinical Trial Phase	Trials
Terminated	3
Withdrawn	1
Completed	1

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for IONSYS

Sponsor Name

Sponsor Name for IONSYS
Sponsor	Trials
Alza Corporation, DE, USA	2
Hospital for Special Surgery, New York	1
The Medicines Company	1

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for IONSYS
Sponsor	Trials
Industry	6
Other	1

Export unavailable in trial.
Subscribe for complete access.